Barbara S. Schilberg, as Managing Director at BioAdvance, plays a pivotal role in an evergreen fund dedicated to early-stage life science. See contact routes.
Barbara S. Schilberg, as Managing Director at BioAdvance, plays a pivotal role in an evergreen fund dedicated to early-stage life science companies. BioAdvance strategically invests in ventures poised to significantly enhance human well-being and quality of life. The fund maintains a concentrated focus on the Mid-Atlantic region, identifying and nurturing promising companies within this geographic area. Under Schilberg's leadership, BioAdvance's portfolio companies have collectively attracted over $4.4 billion in external capital, demonstrating substantial success in securing further investment to fuel their growth and development.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Philadelphia.
Investors like Barbara S. Schilberg · Full investor directory · Investor access · Company funding database